As of 10:30 AM on the 16th, Jinwon Life Sciences is trading at 30,900 KRW, up 3.52% from the previous day. This is a 27.12% decrease compared to September 22. Jinwon Life Sciences is known as a company specializing in the development of gene therapies and gene vaccines.

Today, foreigners are tentatively recorded as net sellers of 18,000 shares. Over the past five days, individual investors have been net buyers of 1,395 shares, while foreigners and institutions have been net sellers of 1,170 shares and 3,825 shares, respectively.


On October 7, Jinwon Life Sciences became an issue in the market with the announcement titled "Publication of paper on the mechanism of action of COVID-19 preventive nasal spray 6.8%...".





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing